Table 1 Characteristics of the participants included in the study
Variable | Controls | Cases | Total |
|---|---|---|---|
Discovery | |||
Participants, N (%) | 76 (46%) | 89 (54%) | 165 |
Male, N (%) | 28 | 40 | 68 (41%) |
Female, N (%) | 48 | 49 | 97 (59%) |
Age, years (SD) | 37 (7.5) | 36 (10.4) | |
Diagnosis | None | PDA 72% | |
PD 28% | |||
Comorbidity:MDD 13.5% | |||
Replication | |||
Participants, N (%) | 169 (56%) | 131 (44%) | 300 |
Male, N (%) | 48 | 48 | 96 (32%) |
Female, N (%) | 121 | 83 | 204 (68%) |
Age, years (SD) | 38 (7.2) | 38 (11.6) | |
Diagnosis | None | PDA 61% | |
PD 39% | |||
Comorbidity:MDD 13% | |||
Meta-analysis | |||
Participants, N (%) | 245 (55%) | 220 (45%) | 465 |
Male, N (%) | 76 | 88 | 164 (34%) |
Female, N (%) | 169 | 132 | 301 (66%) |
Age, years (SD) | 38 (7.3) | 38 (11) | |
Diagnosis | None | PDA 65% | |
PD 35% | |||
Comorbidity:MDD 13% | |||
Dex-treatment study | |||
Participants, N (%) | 29 (41%) | 42 (59%) | 71 |
Male, N (%) | 0 | 0 | 0 |
Female, N (%) | 29 | 42 | 71 |
Age, years (SD) | 44 (11.4) | 44 (13.7) | |
Diagnosis | None | MDD | |
